Clinical
‘Everybody assumes somebody else knows what’s going on.’
A Sydney pharmacist researcher believes the profession could reduce medication harm by “connecting the gaps” in transitions of care Kingston Yeung, a PhD candidate from the University of Sydney, shared …
August MIMS update
Some recent changes to medicines listings, including new products, indications and contraindications New Products Pegunigalsidase alfa (Elfabrio) is a pegylated recombinant form of human alpha-galactosidase-A. The amino acid sequence of …
Call for better access to therapeutic vapes as quit-smoking demand grows
Doctors and pharmacists say limited access, community perceptions and a lack of evidence-based products are holding back the use of therapeutic nicotine vapes. Miranda Cook investigates An Australian doctor wants …
Chronic pain impacts Australians’ mental health: report
Almost three-quarters of Australians living with chronic pain report developing mental health issues as a result of their condition, report reveals Data from Chronic Pain Australia’s 2026 National Pain Report …
Pharmacist involvement ‘essential’ in medical abortion access: researcher
New research has shown that while more GPs are offering early medication abortion, many women still cannot access the service where they live. The study, published in BMJ Sexual & …
Eye health warning for weight loss drugs
The TGA has issued an alert for products in the GLP-1 RA class of medicines, warning they could cause a severe eye disorder in users Product warnings across the class …
‘Pharmacists needed to be seen’
Aged Care Onsite Pharmacist presence boosted “comfort and confidence” in medicines safety, focus group study finds Proactivity and collaboration is key to success as an Aged Care Onsite Pharmacist (ACOP), …
July MIMS update
Some recent changes to medicines listings, including new products, presentations, indications, contraindications and safety changes New products Abaloparatide (Eladynos) is an agonist of the parathyroid hormone receptor 1 (PTHR1). It …
June MIMS update
The latest in medicines news from MIMS, with new products, presentations, indications and safety changes New products Loncastuximab tesirine (Zynlonta) is an antibody-drug conjugate (ADC) targeting CD19. The monoclonal immunoglobulin …
Change up the Black Triangle Scheme, suggest authors
Most people aren’t aware of Australia’s Black Triangle Scheme – including nearly half of health care professionals However, a potential role for pharmacists could include educating their patients about it, …
Program to curb inappropriate medicines use
Monash University aims to boost health practitioners’ confidence to deprescribe unnecessary medicines through its SUPPORT-Meds program The new training initiative is being rolled out with the goal of protecting Australians …
Getting consistent with childhood vaccinations
Growth of pharmacist-administered vaccination is highlighting regulatory and funding inconsistencies, say researchers Australia needs a nationally harmonised regulatory framework for pharmacist-administered vaccinations, say researchers who have conducted a review of …